November 2021: In this Issue
As always, this month’s edition of Contemporary OB/GYN® features multiple peer-reviewed articles that offer in-depth guidance and analyses of key topics in ob/gyn. Here are the highlights of this special technology-centered issue.
MIGS surgeons discuss novel vNOTES technology
Contemporary OB/GYN® held a panel discussion in September with 4 renowned minimally invasive gynecologic surgeons (MIGS) who discussed vaginal natural orifice transluminal endoscopic surgery (vNOTES).
Robotic-assisted surgery for gynecologic procedures
By Bob Kronemyer
The first gynecologic procedures with the Hugo™ robotic-assisted surgery (RAS) system were performed in Panama in July 2021, providing patients with a new minimally invasive treatment.
vNOTES: where does it fit in the gynecologic surgery armamentarium?
By Jon I. Einarsson, MD, PHD, MPH
Once we have this evidence and more clinical experience, we will see where vNOTES falls and whether it is just a temporary “fad” like NOTES or gains wide acceptance among gynecologic surgeons for certain procedures, such as hysterectomy and adnexectomy. Time will tell, but the early results are certainly encouraging.
Management of chronic pelvic pain
By Louise P. King, MD, JD
Optimization of care represents a priority and requires understanding of etiology to effectively diagnose and treat.
.jpeg?w=1500&fit=max&auto=format)
Aspirin and statin prescription for CVD prevention
By Lindsey Carr
In her presentation at the North American Menopause Society 2021 Annual Meeting, Margo B. Minissian, PhD, executive director at the Brawerman Nursing Institute, the Simms/ Mann Family Foundation Endowed Chair of Nurse Education, and assistant professor of cardiology at the Smidt Heart Institute and the Geri and Richard Brawerman Nursing Institute at Cedars- Sinai Medical Center in Los Angeles, California, discussed critical topics related to risk factors and treatments that have led to controversies and confusion surrounding CVD in women.